Description

Cyclohexanecarboxylic acid, 3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-, monopotassium salt, [1S-(1alpha,3beta,4alpha,5alpha)]-, compd. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione (1:1) is a specialized pharmaceutical salt complex designed for enhanced stability and bioavailability. This compound is critical for formulators seeking to combine specific bioactive moieties into a single, standardized active ingredient. It is primarily utilized in the development of advanced nutraceutical and pharmaceutical products where precise molecular interaction is required. Our supply ensures high-purity material suitable for demanding research and manufacturing applications.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of complex active pharmaceutical ingredients (APIs).
• Nutraceutical Formulation: Used in the development of advanced dietary supplements targeting specific metabolic pathways.
• Biochemical Research: Acts as a reference standard or investigational compound in pharmacological and metabolic studies.
• Preclinical Development: Employed in the formulation of drug candidates for stability and efficacy testing.
• Specialty Chemical Synthesis: Utilized as a precursor for creating novel derivatives with potential therapeutic activity.

Basic Information

Product Name	Cyclohexanecarboxylic acid, 3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-trihydroxy-, monopotassium salt, [1S-(1alpha,3beta,4alpha,5alpha)]-, compd. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione (1:1)
CAS No.	7509-32-2
Molecular Formula	C22H23KO11 • C8H10N4O2
Molecular Weight	Contact for details
Synonyms	Chlorogenic Acid Caffeine Potassium Salt; 3-Caffeoylquinic Acid Monopotassium Salt Caffeine Complex; 3-O-Caffeoylquinic Acid Potassium Salt Caffeine Adduct; Caffeoylquinic Acid Potassium Salt Caffeine Compound; Potassium 3-Caffeoylquinate Caffeine; 1:1 Complex of Monopotassium 3-Caffeoylquinate and Caffeine; 3-CQA-K Caffeine; Coffee-specific Chlorogenate Caffeine Salt
EINECS	Contact for details

Quality Control

Our production of this complex adheres to strict quality management systems, ensuring batch-to-batch consistency for critical R&D and manufacturing use. Quality is verified through a comprehensive suite of analytical techniques including HPLC, NMR, and elemental analysis. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are provided with every shipment. We support compliance requirements for pharmaceutical development, and specifications can be aligned with customer-specific protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and easily oxidized; containers must be kept tightly sealed under an inert atmosphere after opening to maintain stability and prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	Contact for details
Heavy Metals	< 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.